A Vitamin B supplement has been recalled due to being incorrectly formulated with niacin rather than niacinamide.
Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...
The US Food and Drug Administration (FDA) has approved Syndax Pharmaceuticals' Revuforj (revumenib) for treating relapsed or ...
An FDA advisory committee has unanimously concluded that oral phenylephrine, a decongestant found in many cold and flu ...
The U.S. patient population for Revuforj in its approved indication is roughly 2,000 according to Syndax. KMT2A leukemias ...
The FDA-cleared Spectral CT 7500 RT, a detector-based computed tomography radiotherapy solution aimed to enhance radiation ...
BrightHeart announced that it received FDA 510(k) clearance for its first AI software for prenatal ultrasound evaluations of ...
Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...
Medical devicemaker BrightHeart has earned FDA clearance for its artificial intelligence software designed to transform prenatal ultrasound evaluations of the fetal heart. Congenital heart defects ...
Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...
The Spokesperson for the Ministry of Education, Kwasi Kwarteng, has questioned the basis of North Tongu MP Samuel Okudzeto ...